Cargando…
Risk factors associated with the occurrence of adverse events in plateletpheresis donation
OBJECTIVE: To recognize the profile of platelet donors and the profile of the plateletpheresis session as well as to investigate the main adverse events of platelet donation using plateletpheresis and associated risk factors. METHODS: This retrospective, cross-sectional and analytical study was perf...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109738/ https://www.ncbi.nlm.nih.gov/pubmed/25031058 http://dx.doi.org/10.1016/j.bjhh.2014.03.008 |
_version_ | 1782327905411399680 |
---|---|
author | Barbosa, Maria Helena da Silva, Karla Fabiana Nunes Coelho, Dieska Quintiliano Tavares, Jordânia Lumênia da Cruz, Luciana Falcão Kanda, Márcia Helena |
author_facet | Barbosa, Maria Helena da Silva, Karla Fabiana Nunes Coelho, Dieska Quintiliano Tavares, Jordânia Lumênia da Cruz, Luciana Falcão Kanda, Márcia Helena |
author_sort | Barbosa, Maria Helena |
collection | PubMed |
description | OBJECTIVE: To recognize the profile of platelet donors and the profile of the plateletpheresis session as well as to investigate the main adverse events of platelet donation using plateletpheresis and associated risk factors. METHODS: This retrospective, cross-sectional and analytical study was performed with a quantitative approach by analyzing 316 donation files from February 2010 to December 2011. The IBM SPSS Statistics program was used for data processing and analysis. The chi-square test was used to verify whether there was an association between factors related to the procedure and the donor, and the adverse events that occurred. RESULTS: The mean age of platelet donors was 40 years old (standard deviation = 8.9), with the prevalent age group being between 40 and 49 years old; the prevalent blood type was O positive (53.8%), the mean duration of the procedure was 73 min and the mean amount of anticoagulant used was 360 mL. The association between procedure duration and the volume of anticoagulant was inverse and statistically significant; the longer the procedure and the greater the volume of anticoagulant used, the less adverse reactions occurred. CONCLUSION: The low incidence of adverse events indicates that the procedure is well tolerated by donors. Obtaining data regarding the incidence of adverse events is a way of promoting a dynamic review of medical and nursing teams to improve the safety and comfort of the donor. |
format | Online Article Text |
id | pubmed-4109738 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Sociedade Brasileira de Hematologia e Hemoterapia |
record_format | MEDLINE/PubMed |
spelling | pubmed-41097382014-07-25 Risk factors associated with the occurrence of adverse events in plateletpheresis donation Barbosa, Maria Helena da Silva, Karla Fabiana Nunes Coelho, Dieska Quintiliano Tavares, Jordânia Lumênia da Cruz, Luciana Falcão Kanda, Márcia Helena Rev Bras Hematol Hemoter Original Article OBJECTIVE: To recognize the profile of platelet donors and the profile of the plateletpheresis session as well as to investigate the main adverse events of platelet donation using plateletpheresis and associated risk factors. METHODS: This retrospective, cross-sectional and analytical study was performed with a quantitative approach by analyzing 316 donation files from February 2010 to December 2011. The IBM SPSS Statistics program was used for data processing and analysis. The chi-square test was used to verify whether there was an association between factors related to the procedure and the donor, and the adverse events that occurred. RESULTS: The mean age of platelet donors was 40 years old (standard deviation = 8.9), with the prevalent age group being between 40 and 49 years old; the prevalent blood type was O positive (53.8%), the mean duration of the procedure was 73 min and the mean amount of anticoagulant used was 360 mL. The association between procedure duration and the volume of anticoagulant was inverse and statistically significant; the longer the procedure and the greater the volume of anticoagulant used, the less adverse reactions occurred. CONCLUSION: The low incidence of adverse events indicates that the procedure is well tolerated by donors. Obtaining data regarding the incidence of adverse events is a way of promoting a dynamic review of medical and nursing teams to improve the safety and comfort of the donor. Sociedade Brasileira de Hematologia e Hemoterapia 2014 2014-04-03 /pmc/articles/PMC4109738/ /pubmed/25031058 http://dx.doi.org/10.1016/j.bjhh.2014.03.008 Text en © 2014 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda. All rights reserved. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/). |
spellingShingle | Original Article Barbosa, Maria Helena da Silva, Karla Fabiana Nunes Coelho, Dieska Quintiliano Tavares, Jordânia Lumênia da Cruz, Luciana Falcão Kanda, Márcia Helena Risk factors associated with the occurrence of adverse events in plateletpheresis donation |
title | Risk factors associated with the occurrence of adverse events in plateletpheresis donation |
title_full | Risk factors associated with the occurrence of adverse events in plateletpheresis donation |
title_fullStr | Risk factors associated with the occurrence of adverse events in plateletpheresis donation |
title_full_unstemmed | Risk factors associated with the occurrence of adverse events in plateletpheresis donation |
title_short | Risk factors associated with the occurrence of adverse events in plateletpheresis donation |
title_sort | risk factors associated with the occurrence of adverse events in plateletpheresis donation |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109738/ https://www.ncbi.nlm.nih.gov/pubmed/25031058 http://dx.doi.org/10.1016/j.bjhh.2014.03.008 |
work_keys_str_mv | AT barbosamariahelena riskfactorsassociatedwiththeoccurrenceofadverseeventsinplateletpheresisdonation AT dasilvakarlafabiananunes riskfactorsassociatedwiththeoccurrenceofadverseeventsinplateletpheresisdonation AT coelhodieskaquintiliano riskfactorsassociatedwiththeoccurrenceofadverseeventsinplateletpheresisdonation AT tavaresjordanialumenia riskfactorsassociatedwiththeoccurrenceofadverseeventsinplateletpheresisdonation AT dacruzlucianafalcao riskfactorsassociatedwiththeoccurrenceofadverseeventsinplateletpheresisdonation AT kandamarciahelena riskfactorsassociatedwiththeoccurrenceofadverseeventsinplateletpheresisdonation |